Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 1
1993 3
1995 3
1996 2
1997 5
1999 3
2000 4
2001 2
2002 2
2003 3
2005 2
2006 4
2007 7
2008 7
2009 7
2010 7
2011 8
2012 3
2013 9
2014 7
2015 9
2016 6
2017 6
2018 6
2019 4
2020 13
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Results by year
Filters applied: . Clear all
Page 1
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Condoluci A, Terzi di Bergamo L, Langerbeins P, Hoechstetter MA, Herling CD, De Paoli L, Delgado J, Rabe KG, Gentile M, Doubek M, Mauro FR, Chiodin G, Mattsson M, Bahlo J, Cutrona G, Kotaskova J, Deambrogi C, Smedby KE, Spina V, Bruscaggin A, Wu W, Moia R, Bianchi E, Gerber B, Zucca E, Gillessen S, Ghielmini M, Cavalli F, Stussi G, Hess MA, Baumann TS, Neri A, Ferrarini M, Rosenquist R, Forconi F, Foà R, Pospisilova S, Morabito F, Stilgenbauer S, Döhner H, Parikh SA, Wierda WG, Montserrat E, Gaidano G, Hallek M, Rossi D. Condoluci A, et al. Among authors: cutrona g. Blood. 2020 May 21;135(21):1859-1869. doi: 10.1182/blood.2019003453. Blood. 2020. PMID: 32267500 Free article.
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma.
Morabito F, Recchia AG, Vigna E, Botta C, Skafi M, Abu-Rayyan M, Atrash M, Galimberti S, Morabito L, Al-Janazreh H, Martino M, Cutrona G, Gentile M. Morabito F, et al. Among authors: cutrona g. Expert Opin Pharmacother. 2020 Jan;21(1):29-38. doi: 10.1080/14656566.2019.1689959. Epub 2019 Nov 18. Expert Opin Pharmacother. 2020. PMID: 31738609 Review.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Morabito F, Tripepi G, Del Poeta G, Mauro FR, Reda G, Sportoletti P, Laurenti L, Coscia M, Herishanu Y, Bossio S, Varettoni M, Murru R, Chiarenza A, Visentin A, Condoluci A, Moia R, Pietrasanta D, Loseto G, Consoli U, Scortechini I, Rossi FM, Zucchetto A, Al-Janazreh H, Vigna E, Martino EA, Mendicino F, Cassin R, D'Arrigo G, Galimberti S, Rago A, Angeletti I, Biagi A, Del Giudice I, Bomben R, Neri A, Fronza G, Monti P, Menichini P, Cutrona G, Jaksic O, Rossi D, Di Raimondo F, Cuneo A, Gaidano G, Polliack A, Trentin L, Foà R, Ferrarini M, Gattei V, Gentile M. Morabito F, et al. Among authors: cutrona g. Eur J Haematol. 2021 Apr;106(4):493-499. doi: 10.1111/ejh.13573. Epub 2021 Jan 28. Eur J Haematol. 2021. PMID: 33378569
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H, Galimberti S, Salah Z, Morabito L, Mujahed A, Hindiyeh M, Dono M, Fais F, Cutrona G, Neri A, Tripepi G, Fronza G, Ferrarini M. Morabito F, et al. Among authors: cutrona g. Expert Opin Investig Drugs. 2020 Aug;29(8):869-880. doi: 10.1080/13543784.2020.1783239. Epub 2020 Jun 27. Expert Opin Investig Drugs. 2020. PMID: 32551999 Review.
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab.
Gentile M, Martino EA, Visentin A, Coscia M, Reda G, Sportoletti P, Mauro FR, Laurenti L, Varettoni M, Murru R, Chiarenza A, Vigna E, Mendicino F, Lucia E, Bossio S, Recchia AG, Moia R, Pietrasanta D, Loseto G, Consoli U, Scortechini I, Rossi FM, Zucchetto A, Al-Janazreh H, Vitale C, Tripepi G, D'Arrigo G, Angeletti I, Bomben R, Neri A, Cutrona G, Fronza G, Di Raimondo F, Gaidano G, Cuneo A, Foà R, Ferrarini M, Trentin L, Gattei V, Morabito F. Gentile M, et al. Among authors: cutrona g. Blood Cancer J. 2020 Sep 16;10(9):92. doi: 10.1038/s41408-020-00358-3. Blood Cancer J. 2020. PMID: 32938904 Free PMC article. No abstract available.
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
Cohen JA, Rossi FM, Zucchetto A, Bomben R, Terzi-di-Bergamo L, Rabe KG, Degan M, Steffan A, Polesel J, Santinelli E, Innocenti I, Cutrona G, D'Arena G, Pozzato G, Zaja F, Chiarenza A, Rossi D, Di Raimondo F, Laurenti L, Gentile M, Morabito F, Neri A, Ferrarini M, Fegan CD, Pepper CJ, Del Poeta G, Parikh SA, Kay NE, Gattei V. Cohen JA, et al. Among authors: cutrona g. Haematologica. 2020 Jun;105(6):1613-1620. doi: 10.3324/haematol.2019.228171. Epub 2019 Oct 3. Haematologica. 2020. PMID: 31582547 Free PMC article.
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients.
Lionetti M, Barbieri M, Favasuli V, Taiana E, Fabris S, Favoino C, Ciceri G, Matis S, Colombo M, Massara R, Reda G, Gentile M, Spina V, Rossi D, Baldini L, Gaidano G, Fais F, Ferrarini M, Morabito F, Cutrona G, Neri A. Lionetti M, et al. Among authors: cutrona g. Hematol Oncol. 2020 Aug;38(3):406-408. doi: 10.1002/hon.2722. Epub 2020 Feb 25. Hematol Oncol. 2020. PMID: 32097987 No abstract available.
Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients.
Ravera S, Ghiotto F, Tenca C, Gugiatti E, Santamaria S, Ledda B, Ibatici A, Cutrona G, Mazzarello AN, Bagnara D, Cardillo M, Zarcone D, Darzynkiewicz Z, Ciccone E, Fais F, Bruno S. Ravera S, et al. Among authors: cutrona g. Sci Rep. 2020 Oct 5;10(1):16519. doi: 10.1038/s41598-020-73594-z. Sci Rep. 2020. PMID: 33020573 Free PMC article.
130 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page